Skip to main content

Peer Review reports

From: Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation

Original Submission
30 Apr 2018 Submitted Original manuscript
17 Jul 2018 Reviewed Reviewer Report - Giuseppe Palmieri
19 Jul 2018 Reviewed Reviewer Report - Pierosandro Tagliaferri
28 Jul 2018 Reviewed Reviewer Report - Paola Queirolo
16 Aug 2018 Author responded Author comments - Gustavo Fernandes
Resubmission - Version 2
16 Aug 2018 Submitted Manuscript version 2
22 Aug 2018 Reviewed Reviewer Report - Pierosandro Tagliaferri
2 Sep 2018 Reviewed Reviewer Report - Giuseppe Palmieri
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
5 Sep 2018 Editorially accepted
12 Sep 2018 Article published 10.1186/s12885-018-4802-y

You can find further information about peer review here.

Back to article page